Patients with respiratory ailments may be administered supplemental breathing gases, such as oxygen, for example, to aid in respiration. These breathing gases may be provided from a breathing gas supply, such as an oxygen tank. A delivery device, such as a nasal cannula, may be coupled to the breathing gas supply and inserted into a patient's nasal passages for delivery of the breathing gas to the patient for inhalation.
Separately, respiratory medications may be administered through inhalation directly to the patient's lungs. These respiratory medications may be aerosolized by a nebulizer in order to generate small particles of the medication, which facilitate distribution throughout the patient's lungs during inhalation.
Nebulizers produce a fine mist for inhalation by a patient. The mist may include a medicament for delivery to the respiratory tract of the patient. A conventional nebulizer uses pressurized air to form a gas jet that creates a venturi vacuum to draw liquid medicament from a liquid reservoir to form a nebulized aerosol for inhalation.
Aspects of the present invention are directed to nebulizer assemblies, nebulizer systems, nebulizer adaptors, and methods for adding medication to a gas flow for inhalation.
In accordance with one aspect of the present invention, a nebulizer assembly includes a reservoir for containing a liquid, a nebulizer for producing an aerosolized gas using the liquid, an aerosolized gas outlet, and a heating chamber. The aerosolized gas outlet is coupled to the nebulizer to pass the aerosolized gas. The heating chamber is disposed around an exterior of the reservoir. The heating chamber includes a heating fluid inlet in fluid communication with the heating chamber for providing heating fluid to the heating chamber and a heating fluid outlet in fluid communication with the heating chamber for discharging the heating fluid from the heating chamber.
In accordance with another aspect of the present invention, a method of heating a medication to be nebulized and providing the nebulized medication to a patient for inhalation includes generating a heated and humidified breathing gas, transmitting the heated and humidified breathing gas through a first lumen in a delivery tube, insulating the heated and humidified breathing gas with a fluid flowing through a second lumen in the delivery tube, discharging the heated and humidified breathing gas from the delivery tube to a chamber, providing a medication in a nebulizer reservoir, transmitting the fluid from the second lumen to a heating cavity surrounding the nebulizer reservoir; thereby heating the medication in the nebulizer reservoir with the fluid, nebulizing the medication in the nebulizer reservoir, combining the nebulized medication with the heated and humidified breathing gas in the chamber, and transmitting the combined nebulized medication and heated and humidified breathing gas to a patient for inhalation.
In accordance with yet another aspect of the present invention, a nebulizer system includes a nebulizer for generating an aerosol mist of a medication, and a breathing gas mixing chamber. The nebulizer includes a nebulizer outlet port. The breathing gas mixing chamber is coupled to the nebulizer outlet port. The breathing gas mixing chamber includes a nebulizer coupling port, a breathing gas inlet, a breathing gas outlet, and an opening between the breathing gas inlet and the breathing gas outlet. The nebulizer coupling port is in fluid communication with the nebulizer outlet port. The breathing gas inlet is adapted to couple to a gas delivery system. The breathing gas outlet is adapted to couple to a breathing device. The opening is in fluid communication with the nebulizer outlet port.
In accordance with still another aspect of the present invention, a method of adding a medication to a gas flow includes nebulizing the medication and entraining the nebulized medication into the gas flow.
In accordance with another aspect of the present invention, a nebulizer adaptor for entraining a nebulized medication into a breathing gas includes a mixing chamber, a nebulizer coupling port, a breathing gas inlet, a breathing gas outlet, and an opening between the breathing gas inlet and the breathing gas outlet. The nebulizer coupling port is adapted to coupled to a nebulizer outlet port. The breathing gas inlet is adapted to couple to a gas delivery system. The breathing gas outlet is adapted to couple to a breathing device. The opening is in fluid communication with the nebulizer coupling port.
The foregoing summary, as well as the following detailed description of preferred embodiment of the inventions, will be better understood when read in conjunction with the appended drawings, which are incorporated herein and constitute part of this specification. For purposes of illustrating the invention, there are shown in the drawings an exemplary embodiment of the present invention. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown. In the drawings, the same reference numerals, are employed for designating the same elements throughout the several figures. In the drawings:
Certain terminology is used herein for convenience only and is not to be taken as a limitation on the present invention. The terminology includes the words specifically mentioned, derivatives thereof and words of similar import. The following describes exemplary embodiments of the invention. It should be understood based on this disclosure, however, that the invention is not limited by the exemplary embodiments of the invention.
Embodiments of the present invention provide a heated nebulizer assembly 100 configured for delivering aerosolized medicament in a heated and humidified breathing gas for inhalation. The aerosolized medicament includes medication in very small particles, e.g., 0.5-1.5 microns in average diameter, allowing the medicament to reach the user's lungs in an efficient manner. Nebulizer assembly 100 is heated in order to warm the medicament prior to the medicament being nebulized so as not to adversely lower the temperature of the heated and humidified breathing gas into which the nebulized medication is mixed prior to inhalation by the user.
Referring to
Medication is contained in a reservoir 116 (e.g., in liquid form; i.e., a liquid medicament) and is aerosolized in nebulizing chamber 118 by the supplied air to form an aerosol. The aerosol exits nebulizer 110 through discharge port 120 in the direction of arrow “A” (shown in
A design of an exemplary nebulizer that may be modified for use as nebulizer 110 is described in U.S. Pat. No. 5,630,409, which is incorporated by reference herein in its entirety. While the nebulizer 110 described in this reference may use a pressurized air supply, other types of nebulizers may alternatively be used. Such nebulizers may include a jet nebulizer, also known as a small-volume nebulizer (SVN). In an exemplary embodiment, one of three types of SVNs are used. A first type of SVN is a pneumatic nebulizer. Pneumatic nebulizers use a pressurized gas stream to draw fluid out of a fluid reservoir and shear the fluid into small particles. Many of the medicaments that are delivered through these nebulizers are used to treat common lung conditions, such as asthma and Chronic Obstructive Pulmonary Disease (COPD).
A second type of SVN is a vented nebulizer. Vented nebulizers make aerosol from pneumatic sources and feature a venting system. When the patient breathes in, he/she inhales a richer mix of aerosol, and when the user exhales, he/she does so through an expiratory valve in the mouthpiece so he/she continues to collect some aerosol in the nebulizer.
A third type of SVN is a breath-actuated device. Breath-actuated devices produce aerosol when the patient inhales and do not produce aerosol when the patient exhales. Because the drug is not constantly being aerosolized, delivery is more efficient and less of the drug is wasted.
Other types of suitable nebulizers for use with the present invention include, by way of non-limiting example, ultrasonic nebulizers that create aerosol using sound waves generated by a vibrating piezo crystal and vibrating mesh nebulizers that are able to generate high overall output respirable fractions. The nebulizers reduce the amount of drug that is wasted by vibrating a mesh or plate with multiple apertures, which aerosolizes virtually all of the drug solution. The vibrating mesh may be active, where the mesh is vibrated directly and acts as an electronic micropump, or passive, where an ultrasonic horn pushes medication through a mesh.
According to one aspect of the invention, a heating chamber 130 surrounds medicament reservoir 116 regardless of the type of nebulizer used in the nebulizer assembly 100. The illustrated heating chamber 130 defines a cavity 131 with the outside wall of nebulizer 110 that is in fluid communication with a fluid manifold 132. Fluid manifold 132 includes a fluid inlet 134 that provides a supply of heated fluid to cavity 131, and a fluid outlet 136 that discharges the heated fluid from cavity 131. Optionally, as shown in
Referring to
Referring to
Referring to
In STEP 500, heated fluid in the second and third lumens of delivery tube 140 insulates a heated and humidified breathing gas flowing through first lumen 140a of delivery tube 140. The heated fluid flowing through second lumen 140b of delivery tube 140 may have a temperature of about 43 degrees Celsius when it reaches manifold 130. In STEP 502, the heated fluid from second lumen 140b passes through manifold 132 to fluid inlet 134, and into cavity 131, which heats the medication in reservoir 116. In STEP 504, the heated fluid then exits cavity 131 through fluid outlet 136, which flows through manifold 132 to third lumen 140c of delivery tube 140 for recirculation by, for example, a heater of a humidifier (not shown).
In STEP 506, high pressure air flows into nebulizer 110 through inlet 112 and, due to a venturi effect, draws medication from reservoir 116 to nebulizing chamber 118 where the medication is aerosolized. In STEP 508, the aerosol exits nebulizer 110 through discharge port 120 to outlet tube 122, and then to a chamber, such as breathing gas flow tee 160.
In STEP 510, the breathing gas flows from first lumen 140a of delivery tube 140, into manifold 132, and then into breathing gas conduit 142 and into a chamber, such as breathing gas flow tee 160, where the breathing gas mixes with the aerosol. The breathing gas flows at a rate of about 10 liters per minute. In STEP 512, the breathing gas/aerosol mixture then flows to nasal cannula 170 in the direction of arrow “C” (shown in
Embodiments of the present invention are also directed to a device for providing a nebulized aerosol gas therapy to a patient delivered via a breathing device, such as a nasal cannula. In an exemplary embodiment, a breathing gas is warmed and humidified for combination with a nebulized aerosol for delivery at a high flow rate. The combined therapy of warm nebulized medication and high flow therapy for patients experiencing stressful respiratory episodes in acute respiratory compromise may provide a comfortable and effective technique in decreasing bronchial responsiveness while maintaining delivery of high FiO2 to improve oxygen saturation level and decrease work of breathing.
An exemplary nebulizer that may be adapted for use with the present invention may be the Aeroneb® Professional nebulizer 601, shown in
During use, the user inserts end 602b of nebulizer inhalation tube 602 into his/her mouth and inhales. As the user inhales, air from the atmosphere flows through end 602b and into nebulizer inhalation tube 602. The inhaled air, with the aerosolized medication entrained therein, then flows through end 602b, and into the user's mouth. Other types of nebulizers suitable for use with the present invention will be understood by one of skill in the art from the description herein.
Referring to
Nebulizer 601 includes a filler cap 608 at the top of nebulizer 601 and an outlet port 609 at the bottom of nebulizer 601. Filler cap 608 may be removed to add liquid medication to nebulizer 601 prior to use.
As shown in
Delivery system 604 may include a delivery tube 612, such as, for example, a delivery tube disclosed in U.S. Pat. No. 7,314,046, which is incorporated fully herein by reference, connected to a supply end of a breathing gas supply (not shown). T-adapter 610 may also connect to nasal cannula 606, providing for fluid communication between delivery system 604 and nasal cannula 606.
Referring to
T-adapter 610 also includes a breathing gas inlet 616 having a first end 616a extending from body 611 and a second end 616b extending through breathing gas mixing chamber 615 of T-adapter 610, terminating within breathing gas mixing chamber 615 between second end 616b of breathing gas inlet 616 and a breathing gas outlet 618. Outlet 618 extends outwardly from body 611 and is adapted to couple to a breathing device, such as nasal cannula 606 (shown in
In use, referring to
Aerosol cloud 603 is drawn through gap 622 and into outlet 618 by a Venturi effect generated by a flow of gas across gap 622, and into outlet 618, thereby entraining the aerosol into the gas flow. The aerosol cloud 603 combines with the gas and exits through outlet 618 for delivery to the patient via nasal cannula 606.
In an alternative embodiment of a nebulizer system shown in
Cross adapter 1010 further includes a drain port 1019 that allows condensed medication and/or humidification vapor (in the form of rainout) to drain away from the flow of breathing gas. Drain port 1019 is disposed at a low point in cross-adapter 1010 and is positioned below nebulizer coupling port 1014 in order to allow gravity to drain liquid to a drain collector 1020 that is coupled to drain port 1019. Drain port 1019 includes a slit 1021 that allows liquid to drain away from cross adapter 1010.
A heat moisture exchanger (HME) absorbent media 1022 may be inserted into drain collector 1020, as illustrated in
Illustrated drain collector 1020 includes a removable cap 1024 that may be removed to replace a used HME-absorbent media 1022 with a fresh HME-absorbent media 1022. Optionally, HME-absorbent media 1022 may be coated or infused with a colorant responsive to fluid present in media 1022 in order to indicate that media 1022 is full of fluid and must be replaced, as well as to ensure the non-reuse of the media 1022. Still optionally, HME-absorbent media 1022 may be coated with an anti-microbial material to reduce the growth of bacteria on/in HME-absorbent media 1022.
Operation of nebulizer system 600 will be discussed with reference to
In STEP 1302, a user (not shown) operates nebulizer 601 to nebulize medication according to the operation of nebulizer 601. In STEP 1304, the nebulized medication is transmitted into mixing chamber 615. Simultaneously with STEPs 1302 and 1304, in STEP 1306, gas, which may be heated and humidified, is transmitted from inlet port 616, across gap 622, and to outlet 618. In STEP 1308, the gas flow draws the nebulized medication into gap 622 to outlet port 618, thereby entraining the nebulized medication into the heated and humidified gas flow.
In STEP 1310, the gas flow with the nebulized medication is transmitted to a breathing device, such as, for example, nasal cannula 606, for inhalation by the patient. Optionally, in STEP 1312, when adapter 1010 is used, nebulized medication that is not drawn into gap 622 may be collected in drain collector 1020. HME-absorbent media 1022 in drain collector 1020 may change color to indicate the presence of fluid in HME-absorbent media 1022, signifying to a user that HME-absorbent media 1022 may be replaced.
In an alternative embodiment of the present invention, illustrated in
Aerosol chamber 1415 is generally bifurcated into two separate pockets 1417 that are separated by a sloped baffle 1418. Opening/passageway 1416 extends vertically through baffle 1418 and provides fluid communication between aerosol chamber 1415 and a through-passage 1420. Pockets 1417 act as a reservoir for residual condensation from aerosol cloud 1403, as well as from any of the heated and humidified breathing gas that may have traveled upward through opening/passageway 1416 and into chamber 1415. Condensed liquid is retained in pockets 1417 and is not delivered to the patient. In order to drain liquid from pockets 1417, adapted 1410 may be removed from nebulizer 601 and up-ended so that the fluid drains from adapter 1410.
Body 1411 also includes through-passage 1420 that extends through body 1411 from a breathing gas inlet end 1422 that is coupled to delivery system 604 to a breathing gas outlet end 1424 that is coupled to nasal cannula 606. As shown in
Breathing gas generated by delivery system 604 is represented by solid arrows in through-passage 1420. Passageway 1416 provides fluid communication between aerosol chamber 1415 and through-passage 1420 such that opening/passageway 1416 forms an opening between breathing gas inlet end 1422 and breathing gas outlet end 1424.
The passage of the breathing gas through through-passage 1420 generates a Venturi effect that draws aerosol cloud 1403 through opening/passageway 1416 and into through-passage 1420, where the medication in aerosol cloud 1403 mixes with the breathing gas, as indicated by both the broken arrows (aerosolized medication) and solid arrows (breathing gas) at breathing gas outlet end 1424 of body 1411. Thus, the medication becomes entrained within the breathing gas.
An exemplary nasal cannula 1706 for use with adapter 1410 is illustrated in
For neonatal use, nasal cannula 1706 may have an overall length of about 4½ inches (about 11.4 cm). This length is shorter than prior art neonatal cannulae, which typically have an overall length of about 13 inches (about 33 cm). The shorter length of cannula 1706 provides for delivery of heated and humidified breathing gas and aerosol mist with minimal loss of temperature and resulting condensation. The length of nasal cannula 1706 also allows a caregiver to hold both the patient and system 1700 during treatment of the patient. However, it will be understood by those of ordinary skill in the art that normal length cannulae may also be used for neonatal patients in conjunction with system 1700.
Further, the inner lumen 1708 of cannula 1706 has a diameter “D” that is about the same as the diameter “D” of breathing gas outlet end 1424. The common diameter eliminates any dead spots between breathing gas outlet end 1424 and inner lumen 608 where condensate may form.
Because of the short length of cannula 1706, nebulizer system 600 may need to be held by a caregiver during treatment. For neonatal use, because only a small volume (about 1 to about 6 ml.) of medication is nebulized in nebulizer 601, the duration of treatment is relatively short, and the caregiver can easily hold nebulizer system 600 for the duration of the treatment.
In another alternative embodiment of a nebulizer system shown in
Angled adapter 1810 also includes a breathing gas inlet 1816 and a breathing gas outlet 1818. Outlet 1818 extends outwardly from body 1811 and is adapted to couple to a breathing device, such as nasal cannula 606 (shown in
As illustrated in
Angled adapter 1810 further includes a pressure-relief port 1819 that allows the relief of pressure away from the flow of breathing gas. Pressure-relief port 1819 is disposed at a side in angled adapter 1810, and is in communication with chamber 1815. Pressure-relief port 1819 may include a hydrophobic membrane 1820. Hydrophobic membrane 1820 prevents build up of pressure within the chambers that may affect the aerosolization ability of the nebulizer. It has been discovered that increased pressure within the chamber 1815 may slow down or inhibit the production of aerosol by the nebulizer. The addition of hydrophobic membrane 1820 allows the venting of excess pressure from within the chamber 1815, thereby allowing the nebulizer 601 to better produce aerosol, while also preventing the aerosol from escaping to atmosphere. Suitable materials for the hydrophobic membrane 1820 will be known to one of ordinary skill in the art from the description herein.
In another alternative embodiment of a nebulizer system shown in
Cup adapter 2210 also includes a breathing gas inlet 2216 and a breathing gas outlet 2218. Outlet 2218 extends outwardly from body 2211 and is adapted to couple to a breathing device. Inlet 2216 extends from body 2211 and is adapted to couple to gas delivery system 604 (shown in
As illustrated in
Operation of the above alternative embodiment of the nebulizer system will be discussed with reference to
In STEP 2602, a user (not shown) operates nebulizer cup 2201 to nebulize medication according to the operation of nebulizer 2201. Operation of nebulizer cup 2201 to nebulize medication will be understood by one of ordinary skill in the art from the description herein.
In STEP 2604, the nebulized medication is entrained in a gas flow. In an exemplary embodiment, a flow of gas, which may be heated and humidified, is transmitted through cup adaptor 2210 from inlet 2216 to outlet 2218. The nebulized medication from nebulizer 2201 is entrained in the gas flow. For example, the gas flow may draw the nebulized medication into the flow via the opening between inlet 2216 and outlet 2218, i.e., due to a Venturi effect. For another example, the nebulized medication may be forced into the gas flow due to an air pressure difference between the nebulizer outlet port 2209 and the adaptor gas outlet 2218.
In STEP 2606, the entrained nebulized medication is passed to a breathing device. In an exemplary embodiment, the entrained nebulized medication is passed to a nasal cannula 2206. Suitable cannulas will be known to one of ordinary skill in the art from the description herein.
It will be understood by one of ordinary skill in the art that the above operation of the nebulizer system may include any of the additional steps set forth with respect to nebulizer system 600.
Although the invention is illustrated and described herein with reference to specific embodiments, the invention is not intended to be limited to the details shown. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the invention.
The present application claims the benefit of U.S. Patent Application No. 61/150,368, entitled “HEATED NEBULIZER DEVICE FOR ADDING AEROSOLIZED MEDICAMENT TO A BREATHING GAS” filed on 6 Feb. 2009, U.S. Patent Application No. 61/228,304, entitled “NEBULIZER SYSTEMS AND METHODS FOR INHALATION THERAPY” filed on 24 Jul. 2009, and U.S. Patent Application No. 61/228,308, entitled “NEBULIZER FOR ACCELERATED AEROSOL DELIVERY WITH FLOW CONTROL” filed on 24 Jul. 2009, all of which are incorporated herein by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
3864326 | Babington | Feb 1975 | A |
4177945 | Schwartz et al. | Dec 1979 | A |
4819625 | Howe | Apr 1989 | A |
4832012 | Raabe et al. | May 1989 | A |
4911157 | Miller | Mar 1990 | A |
5226411 | Levine | Jul 1993 | A |
5461695 | Knoch | Oct 1995 | A |
5630409 | Bono et al. | May 1997 | A |
20040237178 | Landeros | Dec 2004 | A1 |
20080000470 | Minocchieri et al. | Jan 2008 | A1 |
Number | Date | Country |
---|---|---|
2009111135 | Oct 2010 | RU |
Entry |
---|
International Search Report, dated Oct. 18, 2010. |
International Search Report dated Apr. 21, 2013, application No. PCT/US2013/022692. |
Number | Date | Country | |
---|---|---|---|
20100258114 A1 | Oct 2010 | US |
Number | Date | Country | |
---|---|---|---|
61150368 | Feb 2009 | US | |
61228304 | Jul 2009 | US | |
61228308 | Jul 2009 | US |